Cybersecurity company Darktrace, with its first funding from Mike Lynch's Invoke Capital, has just raised its 2nd round of $18m. Sharing some DNA with Mike Lynch's previous enterprise, Autonomy, Darktrace also utilizes Bayesian algorithms, in this case to identify anomalous network activity.
This is another example of the excellent technology coming out of Cambridge.
Cyber security startup Darktrace, which is already backed by Autonomy founder Mike Lynch’s Invoke Capital, has picked up $18 million in new funding, at a valuation of $80 million. Investors this time around include Invoke Capital, along with Talis Capital, Hoxton Ventures and unnamed private individuals. The UK-based company says it will use the new capital to help fuel growth, including expansion into Asia Pacific. Calling itself the leader in “Enterprise Immune System technology”, Darktrace was founded in late 2013, and is based on new mathematics and machine learning developed at the University of Cambridge. It claims to be able to address “advanced” cyber threats, whether insider or external, by detecting previously unseen threats in real-time.